AIM
IMDZ

Alambic Investment Management’s Immune Design Corp. IMDZ Stock Holding History

Alambic Investment Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,000
Closed -$45K – 429
2018
Q3 		$45K Buy
+13,000
New +$48.8K 0.04% 271

Other funds holding IMDZ

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alambic Investment Management's IMDZ Position: Q4 2018 in Review

Alambic Investment Management sold out of Immune Design Corp. (IMDZ) in Q4 2018, closing a stake of 13,000 shares — an estimated $45K sold.

Alambic Investment Management first reported a position in IMDZ in Q3 2018 and held it in 1 quarter. The position peaked at $45K in Q3 2018. 64 funds tracked by Wall St. Rank hold IMDZ as of Q4 2018.

  • Alambic Investment Management reported no remaining Immune Design Corp. position as of Q4 2018 after selling out during the quarter.
  • Alambic Investment Management sold 13,000 Immune Design Corp. shares in Q4 2018, an estimated $45K.
  • Alambic Investment Management first reported a position in Immune Design Corp. in Q3 2018 and held it in 1 quarter.
  • Alambic Investment Management's Immune Design Corp. position peaked at $45K in Q3 2018.
  • 64 funds tracked by Wall St. Rank held Immune Design Corp. as of Q4 2018.

Based on Alambic Investment Management's 13F filing for Q4 2018, filed 12 Feb 2019.